For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Methylergometrine (methylergonovine) (Uterotonic (ergot alkaloid)) – indications: Postpartum haemorrhage due to uterine atony – not recommended by the S2k guideline 2022. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Postpartum haemorrhage due to uterine atony – not recommended by the S2k guideline 2022
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- DGGG/OEGGG/SGGG. S2k-Leitlinie Peripartale Blutungen, Diagnostik und Therapie, AWMF 015/063, 08/2022, Abschnitt 6.1.3 (Methylergometrin wegen Nebenwirkungen und verfügbarer Alternativen nicht einsetzen) und Empfehlungen 6.E14/6.E15 (äußerste Vorsicht, kein i.v.-Bolus).
- Summaries of product characteristics of authorised products – product and section for each dose in the app.